Jan Hasak worked for over 32 years as a patent attorney, and most recently at Genentech, Inc., a major biotechnology company that developed and now sells Herceptin, a cancer drug that she took during her second treatment with cancer. Jan retired from Genentech in May 2008 after working there for over twenty years.
A survivor of breast cancer twice, Jan Hasak penned her first book to inspire others to persevere. Mourning Has Broken: Reflections on Surviving Cancer reveals her honest feelings during her blistering walk through diagnosis, treatment, and beyond. The book also add more...
